ProCE Banner Activity

IMpower131: First-line Atezolizumab + Carboplatin/Pac or nab-Pac vs Carboplatin/nab-Pac in Advanced Squamous NSCLC

Slideset Download
Conference Coverage
Addition of atezolizumab to carboplatin/nab-paclitaxel extended PFS compared with chemotherapy alone in patients with previously untreated metastatic squamous NSCLC.

Released: June 11, 2018

Expiration: June 10, 2019

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Astellas Text

AstraZeneca

Celgene

Eisai

Genentech TEXT Only

Janssen

Merck Oncology

Seagen